Cutler Group’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$12K | – | 3938 |
|
|
2023
Q2 | $12K | Buy |
+1,000
| New | +$78K | ﹤0.01% | 2143 |
|
|
2023
Q1 | – | Sell |
-4,000
| Closed | -$4K | – | 4057 |
|
|
2022
Q4 | $4K | Buy |
+4,000
| New | +$163K | ﹤0.01% | 3292 |
|
|
2022
Q3 | – | Sell |
-4,400
| Closed | -$1K | – | 5072 |
|
|
2022
Q2 | $1K | Sell |
4,400
-32,000
| -88% | -$1.71M | ﹤0.01% | 4562 |
|
|
2022
Q1 | $27K | Buy |
36,400
+4,800
| +15% | +$351K | ﹤0.01% | 2787 |
|
|
2021
Q4 | $178K | Buy |
+31,600
| New | +$2.79M | 0.01% | 1418 |
|
|
2021
Q3 | – | Sell |
-400
| Closed | -$3K | – | 5878 |
|
|
2021
Q2 | $3K | Hold |
400
| – | – | ﹤0.01% | 4752 |
|
|
2021
Q1 | $6K | Sell |
400
-1,400
| -78% | -$192K | ﹤0.01% | 4223 |
|
|
2020
Q4 | $77K | Sell |
1,800
-1,300
| -42% | -$157K | ﹤0.01% | 1705 |
|
|
2020
Q3 | $53K | Sell |
3,100
-5,100
| -62% | -$440K | ﹤0.01% | 1762 |
|
|
2020
Q2 | $5K | Buy |
8,200
+7,700
| +1,540% | +$615K | ﹤0.01% | 3290 |
|
|
2020
Q1 | $1K | Sell |
500
-13,000
| -96% | -$1.06M | ﹤0.01% | 3688 |
|
|
2019
Q4 | $58K | Sell |
13,500
-19,300
| -59% | -$1.7M | ﹤0.01% | 1529 |
|
|
2019
Q3 | $58K | Buy |
32,800
+12,400
| +61% | +$1.41M | 0.01% | 1425 |
|
|
2019
Q2 | $253K | Buy |
20,400
+15,300
| +300% | +$1.54M | 0.02% | 588 |
|
|
2019
Q1 | $40K | Sell |
5,100
-6,400
| -56% | -$545K | ﹤0.01% | 1578 |
|
|
2018
Q4 | $191K | Sell |
11,500
-11,900
| -51% | -$817K | 0.02% | 658 |
|
|
2018
Q3 | $306K | Buy |
23,400
+13,900
| +146% | +$906K | 0.02% | 653 |
|
|
2018
Q2 | $218K | Buy |
9,500
+3,400
| +56% | +$183K | 0.02% | 742 |
|
|
2018
Q1 | $87K | Sell |
6,100
-6,300
| -51% | -$307K | 0.01% | 1279 |
|
|
2017
Q4 | $364K | Sell |
12,400
-56,200
| -82% | -$3M | 0.01% | 677 |
|
|
2017
Q3 | $756K | Sell |
68,600
-60,700
| -47% | -$2.44M | 0.03% | 451 |
|
|
2017
Q2 | $1.03M | Sell |
129,300
-122,600
| -49% | -$3.78M | 0.04% | 407 |
|
|
2017
Q1 | $787K | Buy |
251,900
+83,500
| +50% | +$1.65M | 0.03% | 467 |
|
|
2016
Q4 | $167K | Buy |
168,400
+4,700
| +3% | +$75.9K | 0.01% | 1443 |
|
|
2016
Q3 | $592K | Buy |
163,700
+89,800
| +122% | +$1.58M | 0.03% | 531 |
|
|
2016
Q2 | $241K | Buy |
73,900
+63,600
| +617% | +$479K | 0.01% | 983 |
|
|
2016
Q1 | $5K | Sell |
10,300
-23,700
| -70% | -$152K | ﹤0.01% | 4811 |
|
|
2015
Q4 | $6K | Buy |
+34,000
| New | +$316K | ﹤0.01% | 4691 |
|
Other funds holding EXAS
AIM
Cutler Group's EXAS Position: Q3 2023 in Review
Cutler Group sold out of Exact Sciences (EXAS) in Q3 2023, closing a stake of 203 shares — an estimated $19K sold.
Cutler Group first reported a position in EXAS in Q4 2015 and held it in 26 quarters. The position peaked at $1.01M in Q4 2020. 623 funds tracked by Wall St. Rank hold EXAS as of Q3 2023.
- Cutler Group reported no remaining Exact Sciences position as of Q3 2023 after selling out during the quarter.
- Cutler Group sold 203 Exact Sciences shares in Q3 2023, an estimated $19K.
- Cutler Group first reported a position in Exact Sciences in Q4 2015 and held it in 26 quarters.
- Cutler Group's Exact Sciences position peaked at $1.01M in Q4 2020.
- 623 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2023.
Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.